Result of Psorlyn tablet and Psorlyn oil in Psoriasis(skin disease).

Phase 3

Not yet recruiting

• Conditions: Other specified disorders of the skin and subcutaneous tissue. Ayurveda Condition: Children having classical sign and symptom and diagnosed as psoriasis.,

• Registration Number: CTRI/2021/04/033243
• Lead Sponsor: DrVasishths Ayuremedies

Brief Summary

Psoriasis is one of the common, chronic, autoimmune skin disorder is first evident in approximately one third of affected individuals within the first 2 decade of life. When the onset occurring during childhood about 50% have positive family history of the disease and girls are more frequently affected. The mode of transmission is unknown; a multifactorial type of inheritance has been proposed. There is an association with histocompatibility antigens (HLA).

Modern medicine science uses coltar, PUVA (Psoralen and ultraviolet A), corticosteroids and anti mitotic drug for the treatment of psoriasis and it has serious systemic side effects like liver, kidney failure, bone marrow depletion etc. Thus our duty to establish a safer and effective line of treatment for human welfare.  *Ayurveda*  may provides long lasting effects, results and better life to patient through its uniqueness.

Psorlyn tablet and Psorlyn oil are proposed to evaluate the efficacy and utility in treatment of psoriasis.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-10-05
• Last Update Posted: 2022-04-08

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Children age group between 10 – 16 years of either sex.
• Children having classical sign and symptom and diagnosed as psoriasis.
• Patient should be capable of obeying the instruction related to course of therapy.

Exclusion Criteria

• Patient with k/c/o any chronic systemic illness and allergic disorders.
• Patient with k/c/o any other chronic skin disorder except psoriasis.
• Patient not fulfilling the inclusion criteria.
• Patient/Attendant not willing to give written consent for participation in the research study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in Pasi score.	3 months

Secondary Outcome Measures

Name	Time	Method
To evaluate the safety of trial drug (Tablet Psorlyn & Oil Psorlyn).

Trial Locations

Locations (1)

National institute of Ayurveda, Jaipur, Rajasthan; 🇮🇳 Jaipur, RAJASTHAN, India

National institute of Ayurveda, Jaipur, Rajasthan

🇮🇳Jaipur, RAJASTHAN, India

Dr Neha Kumawat

Principal investigator

7665980352

drnehakumawat94@gmail.com